NCT06610019 Cardiovascular Multimodality Imaging Study
| NCT ID | NCT06610019 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | Non-ischemic Cardiomyopathy |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2023-05-01 |
| Primary Completion | 2031-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2023-05-01 with a primary completion date of 2031-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Determining the etiology of cardiomyopathy is of high clinical importance for optimal treatment strategy and prediction of prognosis. There is increased risk for cardiovascular disease and higher propensity for cardiovascular related mortality among Black and non-Hispanic White patients. Recently, advanced cardiac imaging has become a vital tool in diagnosis and risk stratification of cardiovascular disease. Very limited data is available on the prevalence and characteristics of different cardiovascular diseases in Hispanic and African American minority groups, therefore, studying different racial and ethnic minority groups in the Bronx population is an exceptionally valuable source to determine the prevalence of cardiomyopathies among minority groups along with study survival in this population. This study aims to determine the etiology of cardiovascular disease in a diverse patient population by utilizing various cardiovascular imaging modalities, with a focus on cardiac magnetic resonance (CMR) imaging and to develop risk stratification models by applying advanced cardiovascular imaging markers.
Eligibility Criteria
Inclusion Criteria: * Any adult patient (18 years or older) referred for a cardiovascular magnetic resonance (CMR) imaging study in the Montefiore Health System Exclusion Criteria: * Any patient who does not meet above criteria
Contact & Investigator
Leandro Slipczuk, MD, PhD
PRINCIPAL INVESTIGATOR
Montefiore Medical Center
Frequently Asked Questions
Who can join the NCT06610019 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-ischemic Cardiomyopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06610019 currently recruiting?
Yes, NCT06610019 is actively recruiting participants. Contact the research team at chrpark@montefiore.org for enrollment information.
Where is the NCT06610019 trial being conducted?
This trial is being conducted at The Bronx, United States.
Who is sponsoring the NCT06610019 clinical trial?
NCT06610019 is sponsored by Montefiore Medical Center. The principal investigator is Leandro Slipczuk, MD, PhD at Montefiore Medical Center. The trial plans to enroll 5,000 participants.